The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

BTIG analyst Janine Stichter raised the firm’s price target on Warby Parker (WRBY) to $30 from $22 and keeps a Buy rating on the shares ahead ...

BTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...

Gold and stocks both hit record highs, but experts warn a pullback may be near. Will central bank demand push gold higher, or ...

BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage highlighted ...

Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule. Event: BTIG’s MedTech, Digital Health, Life Science & Diagnostic Tools Conference 2025 ...

Archimedes Tech SPAC Partners II Co. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company ...